[1]ALBUQUERQUE K S, INDIANI J M C, MARTIN M F. Asymptomatic apical aneurysm of the left ventricle with intracavitary thrombus: a diagnosis missed by echocardiography [J].Radiol Bras, 2018, 51(4):274-5.
[2]GERDES A M, CAPASSO J M. Structural remodeling and mechanical dysfunction of cardiac myocytes in heart failure [J]. J Mol Cell Cardiol,1995,27(3): 849-56.
[3]RUZZA A, CZER L S C, ARABIA F, et al. Left Ventricular Reconstruction for Postinfarction Left Ventricular Aneurysm: Review of Surgical Techniques [J]. Tex Heart Inst J,2017,44(5):326-35.
[4]ANZAI T. Inflammatory Mechanisms of Cardiovascular Remodeling [J].Circ J, 2018,82(3):629-35.
[5]ONG S B, HERNANDEZ-RESENDIZ S, CRESPO-AVILAN G E, et al. Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities [J]. Pharmacol Ther,2018,186(73-87.
[6]SILVERMAN H S, PFEIFER M P. Relation between use of anti-inflammatory agents and left ventricular free wall rupture during acute myocardial infarction [J].Am J Cardiol,1987,59(4):363-4.
[7]MINDUR J E, SWIRSKI F K. Growth Factors as Immunotherapeutic Targets in Cardiovascular Disease ·综述· International Clinical Medicine，国际临床医学（ 2 ） 2020，09 ·46·
[8]SHEN W F, TRIBOUILLOY C, MIRODE A, et al. Left ventricular aneurysm and prognosis in patients with first acute transmural anterior myocardial infarction and isolated left anterior descending artery disease [J]. Eur Heart J,1992,13(1): 39-44.
[9]CELEBI S, CELEBI O O, CETIN S, et al. The Usefulness of Admission Plasma NT-pro BNP Level to Predict Left Ventricular Aneurysm Formation after Acute ST-Segment Elevation Myocardial Infarction [J]. Arq Bras Cardiol,2019,113(6):1129-37.
[10]YANCY C W, JESSUP M, BOZKURT B, et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America [J]. Circulation, 2017,136(6): e137-e61.
[11]LEE G Y, SONG Y B, HAHN J Y, et al. Anticoagulation in ischemic left ventricular aneurysm [J]. Mayo Clin Proc, 2015,90(4):441-9.
[12]ROBINSON A A, TRANKLE C R, EUBANKS G, et al. Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi [J]. JAMA Cardiol,2020,
[13]JIANG Y S, CHEN X, XU M, et al. [Clinical analysis of surgical treatment of post-infarction left ventricular aneurysm: a series of 254 patients] [J]. Zhonghua Wai Ke Za Zhi,2020,58(5):369-74.
[14]YANG Y J, HUO Y, XU Y W, et al. Percutaneous Ventricular Restoration Therapy Using the Parachute Device in Chinese Patients with Ischemic Heart Failure: Three-Month Primary End-point Results of PARACHUTE China Study [J]. Chin Med J
(Engl),2016,129(17):2058-62.
[15]COSTA M A, MAZZAFERRI E L, JR., SIEVERT H, et al. Percutaneous ventricular restoration using the parachute device in patients with ischemic heart failure: three-year outcomes of the PARACHUTE
first-in-human study [J]. Circ Heart Fail,2014,7(5):752-8.
[16]VELAZQUEZ E J, LEE K L, O'CONNOR C M, et al. The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial [J]. J Thorac Cardiovasc Surg, 2007,134(6):1540-7.
[17]SUI Y, TENG S, QIAN J, et al. Treatment outcomes and therapeutic evaluations of patients with left ventricular aneurysm [J]. J Int Med Res,2019,47(1):244-51.
